• Vitestro Secures $70M Series B Funding to Advance Autonomous Blood Draw Technology
Vitestro - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Tuesday recap

NewsDealsSocialBlogsVideosPodcasts
HomeVitestro
Vitestro logo

Vitestro

0 followers

About Vitestro

Vitestro develops Aletta, the world’s first autonomous robotic phlebotomy device designed to automate diagnostic blood collection in hospitals and laboratories. The company collaborates with healthcare institutions to advance blood draw workflows, reduce variability in preanalytical steps, and improve patient experience through robotic phlebotomy. Headquartered in the Netherlands, Vitestro positions itself at the forefront of in-hospital blood collection automation and clinical validation. The organization emphasizes partnerships with hospitals worldwide to drive adoption of Aletta and related telemetry and optimization efforts.

Recent News

No recent news for this company.

Recent Deals

Vitestro Secures $70M Series B Funding to Advance Autonomous Blood Draw Technology

March 10, 2026

Key Team Members

Toon Overbeeke

CEO & Co-founder

Brian Joseph

VP of Product Vision & Co-founder

Bob Gerberich

Chief Commercial Officer

Andy McGibbon

VP of Strategy and Business Development

Dewi Hamwijk

Head of People & Culture

Key Facts

HQ Location

Utrecht, Netherlands

Founded

2017

Employees

51 - 200

Status

Private

Website

https://vitestro.com